[
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-1",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#definitiongeneral471717",
    "clean_content": "Definition / general\n\n* Rare mesenchymal neoplasm arising from follicular dendritic cells (FDC) of lymphoid follicles at nodal and extranodal sites* Nodal follicular dendritic cell sarcoma (FDCS) first characterized in 1986 ([Am J Pathol 1986;122:562](2420185))* Extranodal follicular dendritic cell sarcoma first described in 1994 ([Am J Surg Pathol 1994;18:148](8291653))"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-2",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#essentialfeatures471718",
    "clean_content": "Essential features\n\n* Presents as a painless solid mass in nodal and extranodal sites* Behaves as a low grade sarcoma* Immunohistochemistry showing expression of â‰¥ 2 FDC markers is essential for diagnosis"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-3",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Terminology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#terminology471719",
    "clean_content": "Terminology\n\n* Previous designation: follicular dendritic cell tumor (in WHO classification prior to 2008)* Classified under histiocytic / dendritic cell neoplasms in the WHO Classification of Haematolymphoid Tumours (4th revised edition, 2017)* Classified under mesenchymal dendritic cell neoplasms in the category of stroma derived neoplasms of lymphoid tissues in the current WHO Classification of Haematolymphoid Tumours (5th edition, 2023)"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-4",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "ICD coding",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#icdcoding471720",
    "clean_content": "ICD coding\n\n* ICD-10: [C96.4](https://www.icd10data.com/ICD10CM/Codes/C00-D49/C81-C96/C96-/C96.4) - sarcoma of dendritic cells (accessory cells)"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-5",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#epidemiology471721",
    "clean_content": "Epidemiology\n\n* Wide age range; median age is 50 years ([Crit Rev Oncol Hematol 2013;88:253](23755890))* M = F"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-6",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Sites",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#sites471722",
    "clean_content": "Sites\n\n* Lymph nodes: cervical (most common); second most common is axillary or supraclavicular lymph\n  nodes* Extranodal FDCS occurs in a wide variety of sites, including head and neck, gastrointestinal tract, retroperitoneum, tonsil and lung ([Adv Anat Pathol 2021;28:21](32991350))"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-7",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Pathophysiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#pathophysiology471723",
    "clean_content": "Pathophysiology\n\n* See [Molecular / cytogenetics description](https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#FDCSmolecular)"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-8",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Etiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#etiology471724",
    "clean_content": "Etiology\n\n* May arise in the context of follicular dendritic cell proliferation in Castleman disease, hyaline vascular variant* Cases that show association with Epstein-Barr virus (EBV) and predominantly involve the liver or spleen are now considered a distinct entity: [EBV positive inflammatory follicular dendritic cell sarcoma](https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html) ([Am J Surg Pathol 2001;25:721](11395549))"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-9",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Clinical features",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#clinicalfeatures471726",
    "clean_content": "Clinical features\n\n* Nodal and extranodal involvement characterized by slow growing, painless solid mass* B symptoms (fever, night sweats, weight loss) are usually absent* Surgical resection results in complete remission in a majority of cases\n      + ~33% of cases recur locally+ May show late metastasis by hematologic spread to bone, lungs, liver* Rarely, may be associated with paraneoplastic autoimmune multiorgan syndrome (PAMS) ([Am J Surg Pathol 2018;42:1647](30222603))"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-10",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#diagnosis471727",
    "clean_content": "Diagnosis\n\n* Morphologic evaluation supplemented by immunophenotype of follicular dendritic cells is key to diagnosing FDCS* FDCS can coexist with Castleman disease ([Pathologica 2021;113:316](34837090))"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-11",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Radiology description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#radiologydescription471729",
    "clean_content": "Radiology description\n\n* Nodal involvement presents as a homogeneous mass, slightly hypoattenuating on CT, hypointense or isointense on T1 weighted MRI and hyperintense on T2 weighted MRI ([AJR Am J Roentgenol 2021;216:835](33405946))* Extranodal sites of involvement appear heterogeneous with hyperattenuation on unenhanced CT or hyperintense foci on T1 weighted MRI, with or without associated necrosis and calcifications, often accompanied by regional lymphadenopathy ([AJR Am J Roentgenol 2021;216:835](33405946))"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-12",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Radiology images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#radiologyimages471730",
    "clean_content": "Radiology images\n\nImages hosted on other servers:  \n\n[![Small bowel and liver tumor](https://www.pathologyoutlines.com/thumb/lymphnodesFDCsarcoma0THUMBncbi03.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626119/figure/F1/)\n\nSmall bowel and liver tumor\n\n[![Cystic neck lesion](https://www.pathologyoutlines.com/thumb/lymphnodesFDCsarcoma0THUMBncbi05.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220415/figure/fig3/)\n\nCystic neck lesion\n\n[![Liver mass](https://www.pathologyoutlines.com/thumb/lymphnodesFDCsarcoma0THUMBncbi04.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405365/figure/F1/)\n\nLiver mass"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-13",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Prognostic factors",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#prognosticfactors471731",
    "clean_content": "Prognostic factors\n\n* Poor prognostic factors include size of tumor (> 6 cm), nuclear pleomorphism, increased mitoses (> 5/10 high power fields), necrosis and intra-abdominal location ([Arch Pathol Lab Med 2017;141:596](28353378))* Association with paraneoplastic autoimmune multiorgan syndrome follows an aggressive course related to respiratory morbidity and mortality ([Am J Surg Pathol 2018;42:1647](30222603))"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-14",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#casereports471732",
    "clean_content": "Case reports\n\n* Man in his early 30s presented with jaundice, abdominal pain and weight loss ([J Int Med Res 2022;50:3000605221142401](36539966))* 34 year old man with Birt-Hogg-DubÃ© syndrome presented with mass at the ileocecal junction ([Diagn Pathol 2022;17:64](35941667))* 66 year old woman with intermittent right upper quadrant pain ([World J Clin Cases 2019;7:785](30968045))* 66 year old man with no significant medical history presented with right cervical mass ([Mol Clin Oncol 2020;13:23](32765871))* 72 year old man presented with enlarged mediastinal lymph nodes ([Cureus 2023;15:e37715](37206482))"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-15",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Treatment",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#treatment471733",
    "clean_content": "Treatment\n\n* Includes complete surgical resection with or without radiation therapy* Role of adjuvant chemotherapy or radiation is unclear ([Cancers (Basel) 2014;6:2275](25405526))* Role of chemotherapy in advanced disease is not well established ([Crit Rev Oncol Hematol 2013;88:253](23755890))"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-16",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Clinical images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#clinicalimages471734",
    "clean_content": "Clinical images\n\nImages hosted on other servers:  \n\n[![Neck swelling](https://www.pathologyoutlines.com/thumb/lymphnodesFDCsarcoma0THUMBncbi01.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220415/figure/fig1/)\n\nNeck swelling\n\n[![Paraneoplastic pemphigus](https://www.pathologyoutlines.com/thumb/lymphnodesFDCsarcoma0THUMBncbi02.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680329/figure/fig01/)\n\nParaneoplastic pemphigus"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-17",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Gross description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#grossdescription471735",
    "clean_content": "Gross description\n\n* Usually round to ovoid, well circumscribed fleshy solid mass ([Arch Pathol Lab Med 2016;140:186](26910224))* Size ranges from 1 cm to 15 cm, largely dependent on the site of the tumor* May show areas of hemorrhage and necrosis"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-18",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Gross images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#grossimages471736",
    "clean_content": "Gross images\n\nImages hosted on other servers:  \n\n[![Mesentery tumor](https://www.pathologyoutlines.com/thumb/lymphnodesFDCsarcoma0THUMBncbi06.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626119/figure/F2/)\n\nMesentery tumor\n\n[![Small bowel and liver tumor](https://www.pathologyoutlines.com/thumb/lymphnodesFDCsarcoma0THUMBncbi07.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626119/figure/F3/)\n\nSmall bowel and liver tumor\n\n[![Well circumscribed neck tumor](https://www.pathologyoutlines.com/thumb/lymphnodesFDCsarcoma0THUMBncbi08.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220415/figure/fig4/)\n\nWell circumscribed neck tumor\n\n[![Liver tumor](https://www.pathologyoutlines.com/thumb/lymphnodesFDCsarcoma0THUMBncbi09.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405365/figure/F2/)\n\nLiver tumor"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-19",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Microscopic (histologic) description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#microscopichistologicdescription471739",
    "clean_content": "Microscopic (histologic) description\n\n* Oval to spindled cells with dispersed chromatin, small nucleoli, eosinophilic and fibrillar cytoplasm with syncytial borders arranged in fascicles, whorls or storiform patterns* Often binucleate or occasional multinucleate forms, nuclear pseudoinclusions* Perivascular lymphocyte cuffs and admixed population of lymphocytes, eosinophils, plasma cells or neutrophils may be present ([Am J Surg Pathol 2004;28:988](15252304))"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-20",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#microscopichistologicimages471740",
    "clean_content": "Microscopic (histologic) images\n\nContributed by Aishwarya Ravindran, M.D. and Karen L. Rech, M.D.  \n\n[![Storiform growth](https://www.pathologyoutlines.com/imgau/lymphnodesFDCsarcomaRavindran_07nn.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesFDCsarcomaRavindran_07nn.jpg)\n\nStoriform growth\n\n[![Ovoid cells mixed with lymphocytes](https://www.pathologyoutlines.com/imgau/lymphnodesFDCsarcomaRavindran_08nn.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesFDCsarcomaRavindran_08nn.jpg)\n\nOvoid cells mixed with lymphocytes\n\n[![CD21](https://www.pathologyoutlines.com/imgau/lymphnodesFDCsarcomaRavindran_03.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesFDCsarcomaRavindran_03.jpg)\n\nCD21\n\n[![CD35](https://www.pathologyoutlines.com/imgau/lymphnodesFDCsarcomaRavindran_04.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesFDCsarcomaRavindran_04.jpg)\n\nCD35\n\n  \n\n[![Clusterin](https://www.pathologyoutlines.com/imgau/lymphnodesFDCsarcomaRavindran_05.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesFDCsarcomaRavindran_05.jpg)\n\nClusterin\n\n[![CXCL13](https://www.pathologyoutlines.com/imgau/lymphnodesFDCsarcomaRavindran_06.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesFDCsarcomaRavindran_06.jpg)\n\nCXCL13\n\n[![CD3](https://www.pathologyoutlines.com/imgau/lymphnodesFDCsarcomaRavindran_02n.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesFDCsarcomaRavindran_02n.jpg)\n\nCD3\n\n[![TdT](https://www.pathologyoutlines.com/imgau/lymphnodesFDCsarcomaRavindran_09n.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesFDCsarcomaRavindran_09n.jpg)\n\nTdT"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-21",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Virtual slides",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#virtualslides471741",
    "clean_content": "Virtual slides\n\nContributed by Genevieve M. Crane, M.D., Ph.D.  \n\n[![Aggressive B cell lymphoma](https://www.pathologyoutlines.com/thumb/lymphnodesFDCsarcomaCranevirtualslide01.png)](https://pathpresenter.net/public/display?token=59e4ed5e)\n\nAggressive B cell lymphoma"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-22",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Positive stains",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#positivestains471746",
    "clean_content": "Positive stains\n\n* Most sensitive FDC markers: **clusterin**, [CD21](https://www.pathologyoutlines.com/topic/cdmarkerscd21.html), [CXCL13](https://www.pathologyoutlines.com/topic/stainsCXCL13.html) ([J Pathol 2008;216:356](18792075), [Am J Surg Pathol 2004;28:988](15252304))* Most specific FDC markers: [CXCL13](https://www.pathologyoutlines.com/topic/stainsCXCL13.html), [CD21](https://www.pathologyoutlines.com/topic/cdmarkerscd21.html), [CD23](https://www.pathologyoutlines.com/topic/cdmarkerscd23.html), [CD35](https://www.pathologyoutlines.com/topic/cdmarkerscd30to39.html#cd35)* Other FDC markers: [podoplanin / D2-40](https://www.pathologyoutlines.com/topic/stainsD240.html), [SSTR2a](https://www.pathologyoutlines.com/topic/stainsSSTR2A.html), [follicular dendritic cell secreted protein (FDCSP)](https://www.pathologyoutlines.com/topic/FDCSP.html) and **serglycin (SRGN)** ([Am J Clin Pathol 2007;128:776](17951199), [Am J Surg Pathol 2019;43:374](30585825), [Oncotarget 2017;8:16463](28145886))* Other positive stains: [fascin](https://www.pathologyoutlines.com/topic/stainsfascin.html), [PDL1](https://www.pathologyoutlines.com/topic/stainsPDL1.html), **desmoplakin**, [EGFR](https://www.pathologyoutlines.com/topic/stainsegfr.html) and [vimentin](https://www.pathologyoutlines.com/topic/stainsvimentin.html) ([Mod Pathol 2005;18:260](15467709))* [TdT](https://www.pathologyoutlines.com/topic/stainstdt.html) highlights immature T cell lymphoblastic proliferation in 45% of cases; when abundant, this finding may be associated with paraneoplastic autoimmune multiorgan syndrome ([Am J Surg Pathol 2018;42:1647](30222603))"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-23",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Negative stains",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#negativestains471747",
    "clean_content": "Negative stains\n\n* Hematolymphoid markers: [CD1a](https://www.pathologyoutlines.com/topic/cdmarkerscd1a.html), [CD43](https://www.pathologyoutlines.com/topic/cdmarkerscd43.html), [CD45](https://www.pathologyoutlines.com/topic/cdmarkerscd45.html), [CD163](https://www.pathologyoutlines.com/topic/cdmarkerscd160.html#cd163)* Mesenchymal markers: [actin](https://www.pathologyoutlines.com/topic/stainsactin.html), [desmin](https://www.pathologyoutlines.com/topic/stainsdesmin.html), [CD31](https://www.pathologyoutlines.com/topic/cdmarkerscd31.html), [CD34](https://www.pathologyoutlines.com/topic/cdmarkerscd34.html)* Epithelial markers: [EMA](https://www.pathologyoutlines.com/topic/stainsema.html), [keratin](https://www.pathologyoutlines.com/topic/stainsckgeneral.html) ([AE1 / AE3](https://www.pathologyoutlines.com/topic/stainsae1ae3.html), [CAM5.2](https://www.pathologyoutlines.com/topic/stainscam52.html))* Melanoma markers: [HMB45](https://www.pathologyoutlines.com/topic/stainshmb45.html), [S100](https://www.pathologyoutlines.com/topic/stainss100.html), [MelanA](https://www.pathologyoutlines.com/topic/stainsmart1.html), [SOX10](https://www.pathologyoutlines.com/topic/stainssox10.html)* References: [Am J Surg Pathol 2004;28:988](15252304), [J Exp Med 2021;218:e20210790](34424268)"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-24",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Molecular / cytogenetics description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#molecularcytogeneticsdescription471752",
    "clean_content": "Molecular / cytogenetics description\n\n* Proposed molecular pathogenesis involves activation of nuclear factor ÎºÎ² genes as a consequence of recurrent loss of function alterations in nuclear factor ÎºÎ² regulatory genes (*NFKBIA*, *CYLD*, *BIRC3*, *SOCS3*, *TRAF3*, *TNFAIP3*), tumor suppressor genes (*CDKN2A*, *RB1*, *TP53*) and genes involved in immune evasion (*CD274*, *PDCD1LG2*) ([Mod Pathol 2016;29:67](26564005))* Genetic alterations, including copy number variations, somatic mutations involving oncogenes / tumor suppressors (*ZBTB7A*, *SETD2*), chromatin remodeling genes (*CABIN1*, *NCAPH*) and other genes, have been reported ([Blood Adv 2018;2:481](29496669))* *BRAF* V600E or other MAPK pathway mutations are uncommon ([Histopathology 2014;65:261](24720374), [Arch Pathol Lab Med 2023;147:896](36355424))* Chromosome analysis typically reveals a complex karyotype ([In Vivo 2013;27:211](23422480))"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-25",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Sample pathology report",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#samplepathologyreport471755",
    "clean_content": "Sample pathology report\n\n* Lymph node, left neck, excisional biopsy:\n  + Follicular dendritic cell sarcoma, completely excised (see comment)+ Comment: Lymph node architecture is partially effaced by an abnormal population of epithelioid to spindle shaped cells in a whorling pattern. The neoplastic cells have ovoid nuclei, delicate chromatin, small nucleoli and abundant eosinophilic cytoplasm. They are variably admixed with small lymphocytes. Immunohistochemical stains were performed on paraffin sections of the left neck lymph node (CD21, CD23, CD31, CD34, CD35, CD45, clusterin, CXCL13, epithelial membrane antigen, melanA, keratin [AE1 / AE3], HMB45, S100 and terminal deoxynucleotidyl transferase). The abnormal cells are positive for CD21, CD23, CD35, clusterin and CXCL13. There are small numbers of terminal deoxynucleotidyl transferase positive (TdT) cells mixed with the tumor. The neoplastic cells are negative for the other markers tested. Morphology and immunohistochemical stains support the diagnosis of follicular dendritic cell sarcoma."
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-26",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Differential diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#differentialdiagnosis471756",
    "clean_content": "Differential diagnosis\n\n* [Interdigitating dendritic cell sarcoma](https://www.pathologyoutlines.com/topic/lymphnodesinterdigitatingreticulum.html):\n  + Histologically may be indistinguishable from follicular dendritic cell sarcoma and immunohistochemical studies are required for a definite diagnosis+ Positive for [S100](https://www.pathologyoutlines.com/topic/stainss100.html), [CD45](https://www.pathologyoutlines.com/topic/cdmarkerscd45.html), [CD68](https://www.pathologyoutlines.com/topic/cdmarkerscd68.html); negative for FDC markers ([Am J Surg Pathol 2004;28:988](15252304))* [Langerhans cell histiocytosis](https://www.pathologyoutlines.com/topic/lymphnodesLCH.html):\n    + Langerhans cells are oval and recognized by their grooved, folded or indented nuclei with fine chromatin, inconspicuous nucleoli and thin nuclear membrane with moderately abundant and slightly eosinophilic cytoplasm+ Positive for [CD1a](https://www.pathologyoutlines.com/topic/cdmarkerscd1a.html) and **langerin*** [Kaposi sarcoma](https://www.pathologyoutlines.com/topic/softtissuekaposi.html):\n      + Atypical spindled cells form slit-like vascular spaces containing red blood cells+ Positive for [HHV8](https://www.pathologyoutlines.com/topic/stainshhv8.html)* [Spindle cell thymoma](https://www.pathologyoutlines.com/topic/mediastinumthymoma.html):\n        + Site involved is usually anterior mediastinum+ Bland spindled cells with fascicular to whorling growth pattern+ Positive for [keratin](https://www.pathologyoutlines.com/topic/stainsckgeneral.html) ([AE1 / AE3](https://www.pathologyoutlines.com/topic/stainsae1ae3.html))* [Metastatic carcinoma](https://www.pathologyoutlines.com/topic/lymphnodesmetastases.html#adenocarcinoma):\n          + Usually epithelioid cells in sheets, clusters or single cells with marked nuclear atypia+ Positive for [keratin](https://www.pathologyoutlines.com/topic/stainsckgeneral.html) ([AE1 / AE3](https://www.pathologyoutlines.com/topic/stainsae1ae3.html))* [Metastatic melanoma](https://www.pathologyoutlines.com/topic/lymphnodesmetastases.html#melanoma):\n            + Variable cytology including epithelioid or spindled cells with nuclear atypia and prominent nucleoli; cytoplasm may contain brown pigment (melanin)+ Positive for [S100](https://www.pathologyoutlines.com/topic/stainss100.html), [MelanA](https://www.pathologyoutlines.com/topic/stainsmart1.html), [SOX10](https://www.pathologyoutlines.com/topic/stainssox10.html)* [Inflammatory myofibroblastic tumor](https://www.pathologyoutlines.com/topic/softtissueinflammyofibro.html):\n              + Spindled myofibroblasts and fibroblasts with bland nuclei+ Positive for [ALK1](https://www.pathologyoutlines.com/topic/stainsALK.html)* [Pleomorphic sarcoma](https://www.pathologyoutlines.com/topic/softtissuemfhpleo.html):\n                + Pleomorphic cells with a spectrum of cytology and may include spindled, plasmacytoid, epithelioid or multinucleated forms+ Negative for [CXCL13](https://www.pathologyoutlines.com/topic/stainsCXCL13.html), [CD21](https://www.pathologyoutlines.com/topic/cdmarkerscd21.html), [CD23](https://www.pathologyoutlines.com/topic/cdmarkerscd23.html), [CD35](https://www.pathologyoutlines.com/topic/cdmarkerscd30to39.html#cd35)"
  },
  {
    "id": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt-27",
    "source_document": "follicular-dendritic-cell-sarcoma-fdcs_45385_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Additional references",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesFDCsarcoma.html#additionalreferences471757",
    "clean_content": "Additional references\n\n* [Swerdlow: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th Edition, 2017](https://www.amazon.com/exec/obidos/ASIN/928324494X/pathologyoutl-20), [WHO Classification of Tumours Editorial Board: Haematolymphoid Tumours, 5th Edition, 2024](https://www.amazon.com/exec/obidos/ASIN/9283245202/pathologyoutl-20), [Blood 2022;140:1229](35653592)"
  }
]